naltrexone has been researched along with Nausea in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.71) | 18.7374 |
| 1990's | 7 (20.00) | 18.2507 |
| 2000's | 12 (34.29) | 29.6817 |
| 2010's | 12 (34.29) | 24.3611 |
| 2020's | 2 (5.71) | 2.80 |
| Authors | Studies |
|---|---|
| Bowden-Jones, H; Cowlishaw, S; Dowling, N; Lubman, D; Merkouris, S; Thomas, S | 1 |
| Fukumura, K; Kubota, R; Ohnishi, S; Wajima, T | 1 |
| Ishikawa, H; Sato, J; Shino, M; Suzuki, T; Tanaka, R | 1 |
| Apovian, CM; Aronne, L; Burns, C; Dunayevich, E; Kim, D; Rubino, D; Still, C; Wyatt, H | 1 |
| Adam, T; Dallman, M; Daubenmier, J; Epel, E; Hecht, FM; Kristeller, J; Lustig, RH; Woolley, J | 1 |
| Schairer, J; Thapa, SD | 1 |
| Acree, M; Adler, N; Bacchetti, P; Brown, RR; Dallman, M; Daubenmier, J; Epel, ES; Hecht, FM; Laraia, B; Lustig, RH; Mason, AE; Moran, PJ | 1 |
| Dybala, C; Foreyt, JP; Halseth, AE; Herrmann, K; Hong, K; Lam, H | 1 |
| Belfort-DeAguiar, R; Naik, S; Sejling, AS; Sherwin, RS; Szepietowska, B | 1 |
| Fujioka, K; Gilder, K; Halseth, A; Shan, K; Walsh, B | 1 |
| Arbabi, M; Jaberian, M; Malekzad, F; Mohajer, M; Mohammadi, MR; Mohtasham, N; Nasiri, S; Roodsari, MR; Toosi, P | 1 |
| Garbutt, JC | 1 |
| Brewer, R; Johnson, FK; Morris, D; Sekora, D; Stauffer, J; Wang, C; Webster, LR | 1 |
| Kim, SW; Thuras, P; Westermeyer, J; Yoon, G | 1 |
| Chiao, F; Erice, S; Leverone, T; Ma, H; Pearce, S; Quon, R; Tang, J; Wender, RH; White, PF | 1 |
| Bagherzadeh, AH; Ebrahimi-Dariani, N; Farahvash, MJ; Farhangi, E; Froutan, H; Ghofrani, H; Mansour-Ghanaei, F; Mirmomen, S; Nasiri-Toosi, M; Pourrasouli, Z; Taheri, A | 1 |
| Keam, SJ; Plosker, GL; Swainston Harrison, T | 1 |
| Kallio, A; Karhuvaara, S; Löyttyniemi, E; Mäkelä, R; Nurminen, T; Rosberg, M; Simojoki, K; Virta, A | 1 |
| Davidson, D; Gulliver, SB; Longabaugh, R; Wirtz, PW | 1 |
| Lo, MW; Meyer, MC; Schary, WL; Straughn, AB; Whitney, CC | 1 |
| Camu, F; Franck, P; Moerman, I | 1 |
| Croop, RS; Faulkner, EB; Labriola, DF | 1 |
| Chehade, J; Duffy, L; Gajraj, N; Johnson, ER; Joshi, GP; Wesevich, J | 1 |
| Farren, C; Krishnan-Sarin, S; O'Connor, PG; O'Malley, SS | 1 |
| Brady, KT; Sonne, SC | 1 |
| Clark, WM; Kelly, RE; Raps, EC; Tong, DC | 1 |
| Colby, SM; Eaton, CA; Gordon, A; Martin, RA; Monti, PM; Mueller, TI; Rohsenow, DJ; Swift, RM | 1 |
| Kranzler, HR; Oncken, C; Van Kirk, J | 1 |
| Farren, C; Kreek, MJ; Krishnan-Sarin, S; O'Malley, SS; Sinha, R | 1 |
| Alterman, AI; Hayashida, M; O'Brien, CP; Volpicelli, JR | 1 |
| Beauchamp, GK; Bertino, M; Engelman, K | 1 |
| Abboud, TK; Afrasiabi, A; Chai, M; Lee, K; Mantilla, M; Reyes, A; Steffens, Z; Zhu, J | 1 |
| Friedman, JG; Grossman, DJ; Schecter, AJ | 1 |
4 review(s) available for naltrexone and Nausea
| Article | Year |
|---|---|
Pharmacological interventions for the treatment of disordered and problem gambling.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Gambling; Headache; Humans; Naltrexone; Narcotic Antagonists; Nausea; Olanzapine | 2022 |
Efficacy and tolerability of naltrexone in the management of alcohol dependence.
Topics: Alcohol Deterrents; Alcohol Drinking; Alcoholism; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Naltrexone; Narcotic Antagonists; Nausea | 2010 |
Extended-release intramuscular naltrexone.
Topics: Adult; Alcoholism; Animals; Delayed-Action Preparations; Headache; Humans; Injections, Intramuscular; Naltrexone; Narcotic Antagonists; Nausea | 2006 |
Adverse effects of oral naltrexone: analysis of data from two clinical trials.
Topics: Administration, Oral; Adult; Affective Symptoms; Alcoholism; Chi-Square Distribution; Cross-Sectional Studies; Fatigue; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Models, Biological; Models, Psychological; Naltrexone; Narcotic Antagonists; Nausea; Patient Compliance; Secondary Prevention | 2001 |
20 trial(s) available for naltrexone and Nausea
| Article | Year |
|---|---|
Absorption, distribution, metabolism, and excretion of radiolabeled naldemedine in healthy subjects.
Topics: Administration, Oral; Adult; Area Under Curve; Carbon Radioisotopes; Constipation; Healthy Volunteers; Humans; Inactivation, Metabolic; Intestinal Absorption; Male; Naltrexone; Nausea; Oxadiazoles; Tissue Distribution | 2019 |
A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II).
Topics: Adult; Anti-Obesity Agents; Bupropion; Cardiovascular Diseases; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Feeding Behavior; Female; Humans; Hypertension; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Obesity; Overweight; Quality of Life; Risk Factors; Weight Loss | 2013 |
Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial.
Topics: Adult; Behavior, Addictive; Binge-Eating Disorder; Body Mass Index; Body Weight; Bulimia; Eating; Emotions; Female; Humans; Hydrocortisone; Middle Aged; Mindfulness; Motivation; Naltrexone; Narcotic Antagonists; Nausea; Obesity; Opioid Peptides; Receptors, Opioid; Reward; Stress, Psychological; Weight Reduction Programs | 2015 |
Naltrexone/Bupropion extended release-induced weight loss is independent of nausea in subjects without diabetes.
Topics: Adult; Anti-Obesity Agents; Body Mass Index; Bupropion; Combined Modality Therapy; Delayed-Action Preparations; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Hypertension; Incidence; Lost to Follow-Up; Male; Naltrexone; Nausea; Obesity; Overweight; Patient Dropouts; Severity of Illness Index; United States; Weight Loss | 2016 |
Evaluation of the counter-regulatory responses to hypoglycaemia in patients with type 1 diabetes during opiate receptor blockade with naltrexone.
Topics: Adult; Blood Glucose; Connecticut; Cross-Over Studies; Delayed-Action Preparations; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Monitoring; Epinephrine; Female; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin, Regular, Human; Male; Naltrexone; Nausea; Risk; Sensory System Agents | 2017 |
Method-of-use study of naltrexone sustained release (SR)/bupropion SR on body weight in individuals with obesity.
Topics: Adolescent; Adult; Body Weight; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Exercise; Feeding Behavior; Female; Humans; Life Style; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Obesity; Weight Loss; Young Adult | 2017 |
Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Dermatitis, Atopic; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Pain Measurement; Pruritus; Treatment Outcome | 2009 |
Long-term safety and efficacy of morphine sulfate and naltrexone hydrochloride extended release capsules, a novel formulation containing morphine and sequestered naltrexone, in patients with chronic, moderate to severe pain.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Chronic Disease; Constipation; Delayed-Action Preparations; Drug Combinations; Female; Humans; Male; Middle Aged; Morphine; Naltrexone; Narcotic Antagonists; Nausea; Pain; Pain Measurement; Treatment Outcome | 2010 |
Effect of oral naltrexone on pruritus in cholestatic patients.
Topics: Administration, Oral; Adult; Aged; Cholestasis; Dizziness; Headache; Humans; Middle Aged; Muscle Weakness; Naltrexone; Nausea; Pain Measurement; Placebos; Pruritus; Single-Blind Method; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2006 |
Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Topics: Alcohol Drinking; Alcoholism; Double-Blind Method; Drug Administration Schedule; Fatigue; Female; Finland; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Patient Compliance; Placebos; Sleep Initiation and Maintenance Disorders; Substance Abuse Treatment Centers; Temperance; Treatment Outcome | 2007 |
Naltrexone's suppressant effects on drinking are limited to the first 3 months of treatment.
Topics: Adolescent; Adult; Aged; Alcoholism; Anxiety; Double-Blind Method; Drug Administration Schedule; Fatigue; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Patient Compliance; Time Factors; Treatment Outcome; Withholding Treatment | 2007 |
Evaluation of methylnaltrexone for the reduction of postoperative vomiting and nausea incidences.
Topics: Adult; Antiemetics; Double-Blind Method; Female; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Postoperative Complications; Prospective Studies; Quaternary Ammonium Compounds; Vomiting | 1995 |
The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group.
Topics: Adolescent; Adult; Aged; Alcoholism; Antipsychotic Agents; Benzodiazepines; Dizziness; Drug Administration Schedule; Drug Therapy, Combination; Fatigue; Female; Headache; Humans; Male; Middle Aged; Naltrexone; Nausea; Substance Abuse Treatment Centers | 1997 |
Effects of prophylactic nalmefene on the incidence of morphine-related side effects in patients receiving intravenous patient-controlled analgesia.
Topics: Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Morphine; Naltrexone; Narcotic Antagonists; Nausea; Postoperative Complications; Pruritus; Vomiting | 1999 |
Cervene (Nalmefene) in acute ischemic stroke : final results of a phase III efficacy study. The Cervene Stroke Study Investigators.
Topics: Acute Disease; Aged; Aged, 80 and over; Brain Ischemia; Dose-Response Relationship, Drug; Double-Blind Method; Dynorphins; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Neuroprotective Agents; Receptors, Opioid, kappa; Risk Factors; Survival Analysis; Treatment Failure | 2000 |
Predictors of compliance with naltrexone among alcoholics.
Topics: Adult; Alcohol Drinking; Alcoholism; Fatigue; Female; Humans; Male; Middle Aged; Naltrexone; Nausea; Patient Compliance; Placebos; Time Factors | 2000 |
Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
Topics: Adrenocorticotropic Hormone; Adult; Alcohol Drinking; Alcoholism; Central Nervous System Depressants; Ethanol; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Naltrexone; Narcotic Antagonists; Nausea; Pituitary-Adrenal System; Psychiatric Status Rating Scales; Surveys and Questionnaires | 2002 |
Naltrexone in the treatment of alcohol dependence.
Topics: Adult; Alcohol Drinking; Alcoholism; Ambulatory Care; Combined Modality Therapy; Double-Blind Method; Humans; Male; Naltrexone; Nausea; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Psychotherapy; Recurrence; Severity of Illness Index; Treatment Outcome | 1992 |
Naltrexone, an opioid blocker, alters taste perception and nutrient intake in humans.
Topics: Adult; Affect; Analysis of Variance; Eating; Food Preferences; Humans; Hunger; Male; Naltrexone; Narcotic Antagonists; Nausea; Satiety Response; Taste | 1991 |
Prophylactic oral naltrexone with intrathecal morphine for cesarean section: effects on adverse reactions and analgesia.
Topics: Administration, Oral; Adult; Cesarean Section; Double-Blind Method; Female; Humans; Injections, Spinal; Morphine; Naltrexone; Nausea; Pain, Postoperative; Pregnancy; Pruritus; Randomized Controlled Trials as Topic; Sleep | 1990 |
11 other study(ies) available for naltrexone and Nausea
| Article | Year |
|---|---|
A preliminary study of the effect of naldemedine tosylate on opioid-induced nausea and vomiting.
Topics: Aged; Analgesics, Opioid; Antiemetics; Constipation; Female; Humans; Incidence; Male; Middle Aged; Morphine; Naltrexone; Narcotic Antagonists; Nausea; Oxycodone; Receptors, Opioid; Retrospective Studies; Vomiting | 2020 |
A new biomarker of hedonic eating? A preliminary investigation of cortisol and nausea responses to acute opioid blockade.
Topics: Adiposity; Adult; Biomarkers; Body Mass Index; Bulimia; Cross-Sectional Studies; Eating; Energy Intake; Feeding Behavior; Female; Humans; Hydrocortisone; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Obesity; Overweight; Receptors, Opioid; Surveys and Questionnaires | 2014 |
Narcotic-induced pain.
Topics: Abdominal Pain; Adult; Analgesics, Opioid; Anorexia; Chronic Disease; Diabetes Mellitus, Type 1; Drug Administration Schedule; Endoscopy, Gastrointestinal; Gastroparesis; Humans; Hypertension; Kidney Failure, Chronic; Male; Naltrexone; Narcotic Antagonists; Nausea; Neuralgia; Quaternary Ammonium Compounds; Substance Withdrawal Syndrome; Treatment Outcome; Vomiting | 2015 |
Corrections.
Topics: Arthritis; Capsules; Drug Combinations; Etanercept; Humans; Injections; Isoquinolines; Naltrexone; Nausea; Oxycodone; Palonosetron; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Tumor Necrosis Factor-alpha; Vomiting | 2016 |
Safety, tolerability, and feasibility of high-dose naltrexone in alcohol dependence: an open-label study.
Topics: Adult; Alcoholism; Dizziness; Feasibility Studies; Female; Humans; Male; Middle Aged; Naltrexone; Nausea; Pilot Projects; Treatment Outcome | 2011 |
The effect of clonidine on gastrointestinal side effects associated with ultra-rapid opioid detoxification.
Topics: Adrenergic alpha-Agonists; Adult; Clonidine; Diarrhea; Female; Gastrointestinal Diseases; Humans; Hypnotics and Sedatives; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Nausea; Opioid-Related Disorders; Retrospective Studies; Substance Withdrawal Syndrome; Treatment Outcome; Vomiting | 2003 |
Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.
Topics: Administration, Oral; Adult; Dosage Forms; Dose-Response Relationship, Drug; Half-Life; Humans; Kinetics; Male; Naloxone; Naltrexone; Nausea; Tablets; Therapeutic Equivalency | 1984 |
Cancer pain remedy wins orphan drug status.
Topics: Blood-Brain Barrier; Constipation; Drug Therapy, Combination; Humans; Morphine; Naltrexone; Narcotic Antagonists; Nausea; Neoplasms; Orphan Drug Production; Pain; Quaternary Ammonium Compounds; United States; United States Food and Drug Administration | 1996 |
Naltrexone-induced nausea in patients treated for alcohol dependence: clinical predictors and evidence for opioid-mediated effects.
Topics: Adolescent; Adult; Age Factors; Aged; Alcoholism; Female; Humans; Logistic Models; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Sex Factors; Temperance | 2000 |
Naltrexone for individuals with comorbid bipolar disorder and alcohol dependence.
Topics: Adult; Alcoholism; Bipolar Disorder; Diagnosis, Dual (Psychiatry); Female; Humans; Naltrexone; Narcotic Antagonists; Nausea | 2000 |
Clinical use of naltrexone (EN-1639A): Part I: Safety and efficacy in pilot studies.
Topics: Adult; Ambulatory Care; Drug Evaluation; Female; Heroin Dependence; Humans; Legislation, Drug; Male; Middle Aged; Naloxone; Naltrexone; Nausea; New York City; Pilot Projects; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; United States | 1974 |